Abstract
The practical management of the problem of erythroblastosis depends primarily on the prenatal determination of which pregnancies might result in an erythroblastotic infant. The physician primarily concerned with the care of the child must attend the delivery of every Rh-negative woman whose serum contains anti-Rh antibodies. At present, prompt confirmation of the suspected diagnosis immediately following birth and immediate exchange transfusion in infants with laboratory or clinical evidence of the disease are necessary to reduce morbidity and prevent kernicterus.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ALLEN F. H., Jr, DIAMOND L. K., JONES A. R. Erythroblastosis fetalis. IX. The problems of stillbirth. N Engl J Med. 1954 Sep 16;251(12):453–459. doi: 10.1056/NEJM195409162511201. [DOI] [PubMed] [Google Scholar]
- ARNOLD D. P., WITEBSKY E., SELKIRK G. H., ALFORD K. M. Clinical and serological experiences in treating hemolytic disease of the newborn. J Pediatr. 1955 May;46(5):520–530. doi: 10.1016/s0022-3476(55)80257-0. [DOI] [PubMed] [Google Scholar]